The Year Of Industry Consolidation

Across the cannabis industry, we are seeing a trend toward consolidation. The New Year kicked off with the Jazz Pharmaceuticals acquisition of GW Pharmaceuticals, the maker of Epidiolex, for a whopping $7.2 Billion. In April, Tilray completed a merger with Aphria creating the world’s largest cannabis company by revenue. Today, all signs point to continued industry consolidation.

While every merger and acquisition transaction is unique, cannabis businesses seeking to buy, sell, or merge will face common issues with respect to contract provisions and structures. In addition, M&A transactions should always consider the complex nexus of cannabis-related regulatory issues.

 

The Hoban Law Group has a team of seasoned corporate attorneys with extensive experience negotiating and structuring M&A transactions. It is imperative to work with competent counsel when undertaking a merger or acquisition. This is the only way to assure a comprehensive contract that protects a client’s interests.

Primary Sponsor

Top Marijuana Blog